Innovation Pharmaceuticals Inc (IPIX)

[GreenBioAnalyst]

Fair value at 48 to 82c to account for peer-review release. Global recognition of Bril, social media, news, and etc. Their valuation is still very cheap.

Here's why...

A small grant will allow us to initiate a Phase II trial for moderate and/ or mild patients. IND first and possibly EIND is not out of the question. Those milestones will push our valuation to up to $600mil to $700mil market valuation. Huge shorts covering at over $1 to fill above the $1.84 gap and push as to $2.

Can you imagine if the total grants exceed over $60mil or $80mil? This will push IPIX's valuation to at least $1.2b to extend other clinical trials and cover all cv19 sequelae.

The second wave of cv19 is coming that could result in trillions of global business losses. Vaccines are unlikely to be ready until next spring, IMO.

Great buying opportunity to buy, accumulate,e, and hold to achieve the next $2 price target.

Lastly, BRIL WILL BE A GUARANTEED SUCCESS AS THERAPEUTIC DRUG FOR CV19! The only question is, what are you going to do now with that information at this price before grant funding for Phase II is announced??

Know and understand why you buy and hold IPIX at this cheap price level!

GLTAL
GBA